161 related articles for article (PubMed ID: 36731896)
1. Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry.
Suh DH; Ha HI; Lee YJ; Lim J; Won YJ; Lim MC
J Gynecol Oncol; 2023 Mar; 34(2):e39. PubMed ID: 36731896
[TBL] [Abstract][Full Text] [Related]
2. Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009.
Oh CM; Jung KW; Won YJ; Shin A; Kong HJ; Jun JK; Park SY
PLoS One; 2013; 8(8):e72012. PubMed ID: 23977194
[TBL] [Abstract][Full Text] [Related]
3. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.
Smith HO; Tiffany MF; Qualls CR; Key CR
Gynecol Oncol; 2000 Aug; 78(2):97-105. PubMed ID: 10926787
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer incidence and survival in Korea: 1993-2002.
Chung HH; Jang MJ; Jung KW; Won YJ; Shin HR; Kim JW; Lee HP;
Int J Gynecol Cancer; 2006; 16(5):1833-8. PubMed ID: 17009979
[TBL] [Abstract][Full Text] [Related]
5. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among Tunisian women.
Missaoui N; Trabelsi A; Landolsi H; Jaidaine L; Mokni M; Korbi S; Hmissa S
Asian Pac J Cancer Prev; 2010; 11(3):777-80. PubMed ID: 21039053
[TBL] [Abstract][Full Text] [Related]
6. Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry.
Yagi A; Ueda Y; Kakuda M; Tanaka Y; Ikeda S; Matsuzaki S; Kobayashi E; Morishima T; Miyashiro I; Fukui K; Ito Y; Nakayama T; Kimura T
Cancer Res; 2019 Mar; 79(6):1252-1259. PubMed ID: 30635276
[TBL] [Abstract][Full Text] [Related]
7. Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea.
Ha HI; Kim JH; Lim J; Song YJ; Won YJ; Lim MC
J Gynecol Oncol; 2024 Jan; 35(1):e31. PubMed ID: 38072401
[TBL] [Abstract][Full Text] [Related]
8. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia.
Stockton D; Cooper P; Lonsdale RN
J Med Screen; 1997; 4(1):40-3. PubMed ID: 9200062
[TBL] [Abstract][Full Text] [Related]
9. Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database.
Shin A; Won YJ; Jung HK; Kong HJ; Jung KW; Oh CM; Choe S; Lee J
J Gastroenterol Hepatol; 2018 Dec; 33(12):1961-1968. PubMed ID: 29802647
[TBL] [Abstract][Full Text] [Related]
10. Cancer of the uterine cervix in Norway by histologic type, 1970-84.
Eide TJ
J Natl Cancer Inst; 1987 Aug; 79(2):199-205. PubMed ID: 3474452
[TBL] [Abstract][Full Text] [Related]
11. Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015.
Lim MC; Won YJ; Ko MJ; Kim M; Shim SH; Suh DH; Kim JW
J Gynecol Oncol; 2019 Jan; 30(1):e38. PubMed ID: 30574686
[TBL] [Abstract][Full Text] [Related]
12. Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study.
Kim SI; Kim JH; Lee C; Ha J; Jung KW; Lim MC
J Gynecol Oncol; 2023 Jan; 34(1):e9. PubMed ID: 36366811
[TBL] [Abstract][Full Text] [Related]
13. Changing patterns of anal canal carcinoma in the United States.
Nelson RA; Levine AM; Bernstein L; Smith DD; Lai LL
J Clin Oncol; 2013 Apr; 31(12):1569-75. PubMed ID: 23509304
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of Cervical Cancer in the Era of Concurrent Chemoradiation from National Database in Korea: A Comparison between Squamous Cell Carcinoma and Adenocarcinoma.
Lee JY; Kim YT; Kim S; Lee B; Lim MC; Kim JW; Won YJ
PLoS One; 2015; 10(12):e0144887. PubMed ID: 26660311
[TBL] [Abstract][Full Text] [Related]
15. Uterine cervical adenocarcinomas and squamous carcinomas in Bombay: 1965-1990.
Krishnamurthy S; Yecole BB; Jussawalla DJ
J Obstet Gynaecol Res; 1997 Dec; 23(6):521-7. PubMed ID: 9433043
[TBL] [Abstract][Full Text] [Related]
16. Trends in incidence and survival of patients with vulvar cancer in an Asian country: Analysis of the Korean Central Cancer Registry 1999-2018.
Shin DW; Bae J; Ha J; Lee WM; Jung KW
Gynecol Oncol; 2022 Feb; 164(2):386-392. PubMed ID: 34893346
[TBL] [Abstract][Full Text] [Related]
17. Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991.
Levi F; La Vecchia C; Randimbison L; Te VC
Ann Oncol; 1994 Oct; 5(8):747-52. PubMed ID: 7826908
[TBL] [Abstract][Full Text] [Related]
18. Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models.
Reimers LL; Anderson WF; Rosenberg PS; Henson DE; Castle PE
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):792-800. PubMed ID: 19258470
[TBL] [Abstract][Full Text] [Related]
19. Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15-29 Years in the United States, 1999-2017: An Ecologic Study.
Mix JM; Van Dyne EA; Saraiya M; Hallowell BD; Thomas CC
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):30-37. PubMed ID: 33082207
[TBL] [Abstract][Full Text] [Related]
20. Incidence trends in invasive uterine cervix cancer and carcinoma in situ in Incheon, South Korea.
Boo YK; Kim WC; Lee HY; Leem JH; Lee MH; Leem JS
Asian Pac J Cancer Prev; 2011; 12(8):1985-8. PubMed ID: 22292638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
